This inventor holds 3 USPTO granted patents and 5 published patent applications and 1 EPO patent. Top assignees: Elanco Tiergesundheit Ag, F. Hoffmann-La Roche Ag. Active years: 2019-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019-2026
Title: Paolo Tosatti: Innovating Ectoparasite Control from Binningen, CH
Introduction: Paolo Tosatti is a skilled inventor based in Binningen, Switzerland, renowned for his contributions to the field of veterinary health. With two patents to his name, Tosatti's work primarily focuses on developing compounds for controlling ectoparasites, significantly impacting animal health.
Latest Patents: Among his notable inventions, Tosatti has filed patents for "Heteroaryl-1,2,4-triazole and heteroaryl-tetrazole compounds for controlling ectoparasites." These compounds are designed with a specific formula that includes various chemical constituents, such as X being either O or S, while Y represents either a direct bond or CH. The compounds derived from these formulas prove to be effective in managing ectoparasitic infestations on animals, offering a vital solution in veterinary medicine.
Career Highlights: Tosatti's career is marked by his tenure at Elanco Tiergesundheit AG, a leading company in animal health, where he has been able to channel his innovative ideas into practical applications. His latest patents reflect his commitment to developing solutions that enhance the well-being of animals by effectively controlling ectoparasites.
Collaborations: Collaboration is key in the field of innovations, and Paolo Tosatti has worked alongside colleagues such as Jean-Yves Wach. Together, they strive to advance the development of new compounds that address the challenges faced in animal health, ensuring better outcomes for pets and livestock alike.
Conclusion: Paolo Tosatti's contributions to the field of veterinary medicine through his innovative patents are significant. His work, especially in the development of compounds for controlling ectoparasites, showcases the importance of research and innovation in improving animal health and welfare. As he continues to work with Elanco Tiergesundheit AG, the impacts of his inventions are likely to benefit the industry and the animals it serves for years to come.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile